NeoTract Announces American Urological Association (AUA) Recommendation of UroLift® System as a Standard of Care Option for the Treatment of Enlarged Prostate

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE: TFX) focused on addressing unmet needs in the field of urology, today announced that the American Urological Association (AUA) has recommended the use of the UroLift® System as a standard of care treatment for lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). In Leggi tutto…